Nootropic Research Initiative on Cognition, Health and Aging
Research partnership opportunity to systematically assess how nootropic nutraceuticals (creatine, GAA, nitrates, omega-3s, curcumin, citicoline, paraxanthine, caffeine) improve cognitive function, memory, focus, and quality of life in adults aged 45 and older. Builds on extensive prior research in exercise and nutritional interventions.
Overview
This research initiative systematically evaluates how dietary nutraceutical substances that enhance blood flow, oxygen delivery, energy availability, and neural activity can improve focus, memory, and mental fatigue resistance in adults aged 45 and older. The program targets an emerging area in active nutrition and aging research: understanding how cognitive-enhancing nutrients (nootropics) affect cognitive function and may delay age-associated cognitive decline. The research team has extensive prior experience studying the cognitive effects of nootropic compounds including caffeine, p-synephrine, inositol-enhanced arginine silicate, ashwagandha, paraxanthine, fucoxanthin, and pre-workout supplements in younger and older populations.
Technical specifications
Research approach:
- Placebo-controlled, double-blind, randomized study design
- Initial cohort of 80 late middle-aged and older adults
- Participants randomly assigned to placebo, creatine monohydrate (CrM), guanidinoacetic acid (GAA), or CrM + GAA at 2 x 10 g/d
- Fasting blood samples collected at 0, 1, and 4 weeks to assess clinical safety and side effects
- Cognitive testing battery administered one hour post-supplement, including Mini Mental State Examination (MMSE), Wechsler Memory Scale IV, MAC-Q, and COMPASS cognitive function battery
Compound categories under investigation:
- Energy availability: Creatine monohydrate and GAA
- Blood flow: Nitrates and inositol-enhanced arginine silicate
- Anti-inflammatory: Omega-3 fatty acids, curcumin, tart cherry
- Neural stimulation: Citicoline, paraxanthine, and caffeine
Study design flexibility: Additional arms can be incorporated to evaluate different nutrients and combinations, enabling systematic comparison across compound categories.
Technology readiness level
The research team has completed prior validation studies on multiple nootropic compounds in both younger and older populations. The proposed creatine and GAA study is ready to launch as the first phase, with planned expansion to additional compound arms (nitrates, omega-3 fatty acids, citicoline, and others) following completion of the initial trial. This phased approach allows for systematic evaluation of promising nootropic compounds on cognitive function in populations who may benefit most from cognitive support.
About Texas A&M University, College Station
Texas A&M University in College Station is a comprehensive public research university and the flagship of The Texas A&M University System, combining broad academic strengths with a strong applied‑research culture. Industry collaborates on the Texas A&M‑RELLIS campus—an integrated education, research and testing environment that supports large‑scale experimentation and proving grounds—and through the Texas A&M Transportation Institute’s facilities in Bryan‑College Station. A statewide extension network connects university expertise to companies and communities across all Texas counties, enabling rapid piloting and deployment. Research is supported by competitive federal funding from agencies such as NSF, NIH, DOE, USDA and DoD, alongside state and industry sponsorship. Texas A&M Innovation provides IP management, licensing and commercialization pathways across the system.
Inquire about this partnering listing
Looking for
delivered to your inbox.